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Abstract
Background: The Boston Carpal Tunnel Questionnaire (BCTQ) is a disease-specific measure of
self-reported symptom severity and functional status. It is frequently used in the reporting of
outcomes from trials into interventions for carpal tunnel syndrome. We conducted a systematic
review of published studies on the psychometric properties of the BCTQ to determine the level
of evidence on the instrument's validity, reliability and responsiveness to date.
Methods: A search of the databases Medline, CINAHL, AMED and PsychInfo was conducted to
retrieve studies which investigated one or more of the psychometric properties of the BCTQ. Data
abstraction was undertaken by the first two authors.
Results: Ten studies were retrieved which met the inclusion criteria. One study evaluated face and
content validity (43 patients) eight studies assessed construct validity (932 patients), four studies
tested reliability (126 patients) and nine studies assessed responsiveness (986 patients).
Interpretability was evaluated in one study and acceptability in eight studies (978 patients).
Conclusion: The BCTQ is a standardised, patient-based outcome measure of symptom severity
and functional status in patients with carpal tunnel syndrome. The evidence base of the
psychometric properties indicates that the BCTQ is a valid, reliable, responsive and acceptable
instrument and should be included as a primary outcome measures in future CTS trials.
Background
The effectiveness of surgical and non-surgical interven-
tions for carpal tunnel syndrome (CTS) has been investi-
gated through randomised controlled trials and
systematic reviews [1-4]. The outcomes reported in trials
of interventions for CTS are wide ranging and include
relief of symptoms, time to resumption of activities and
work, clinical measures of sensation, strength and dexter-
ity, electrophysiological studies and the use of validated
patient-based questionnaires of symptom relief, func-
tional ability and health-related quality of life and satis-
faction. The use of patient-based outcome measures is
becoming more wide-spread and reflects the need to
incorporate patient perspectives on outcome[5]. Some
patient-based questionnaires are region-specific, that is,
they are applicable to the upper limb only, e.g. the Patient
Evaluation Measure (PEM) [6] and Disabilities of the
Arm, Shoulder and Hand (DASH) [7] whilst others are
generic measures of quality of life, for example, the Medi-
cal Outcomes Short-Form-36 (SF-36)[8]. In order to
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encompass all relevant outcomes a combination of
generic and specific measures need to be employed [9].
The Boston Carpal Tunnel Questionnaire (BCTQ), also
referred to as the Levine scale[10], Brigham and Womens'
Carpal Tunnel Questionnaire [11] and Carpal Tunnel
Syndrome Instrument [12], is a patient-based outcome
measure that has been developed specifically for patients
with CTS. It has two distinct scales, the Symptom Severity
Scale (SSS) which has 11 questions and uses a five-point
rating scale and the Functional Status Scale (FSS) contain-
ing 8 items which have to be rated for degree of difficulty
on a five-point scale. Each scale generates a final score
(sum of individual scores divided by number of items)
which ranges from 1 to 5, with a higher score indicating
greater disability. The BCTQ has been used as an outcome
measure in clinical studies, and has also undergone exten-
sive testing for validity, reliability and responsiveness. The
purpose of this paper is to review and synthesise the evi-
dence on the psychometric properties of the BCTQ pub-
lished to date, and to make recommendations regarding
its use in practice and research.
Methods
Search strategy and review criteria
The review considered all studies designed primarily to
investigate an aspect of validity, reliability or responsive-
ness of the BCTQ in patients with carpal tunnel syn-
drome. We also considered any studies reporting on
interpretability and patient acceptability of the BCTQ.
The bibliographic databases Medline (1966–2005),
CINAHL (1982–2005), AMED (1985–2005) and Psy-
cINFO (1887–2005) were searched using the following
MeSH terms: carpal tunnel syndrome, outcome assess-
ment, questionnaires, psychometrics, validity, reliability,
reproducibility, responsiveness. Keyword searches were
also made using 'Boston Carpal Tunnel Questionnaire'
and 'carpal tunnel instrument'. Bibliographies of the arti-
cles obtained were checked to identify any studies not
retrieved through the electronic databases. The search was
limited to English language articles only.
The title and abstract of the articles retrieved were read
and selected for inclusion if they fulfilled the following
criteria: a prospective, observational study or clinical trial
designed to evaluate validity, reliability, responsiveness,
acceptability or interpretability of the BCTQ in patients
with CTS. The full text was obtained for those articles
which met the inclusion criteria.
A data extraction form was developed and used to sum-
marise information regarding the psychometric properties
assessed including design, methods, sample and main
results of those studies included (see Additional file 1).
Each article was independently read by the first two
authors and a data extraction form completed. Any dis-
crepancies between reviewers were discussed and agreed.
The data from the studies were summarised in tables, and
then qualitatively synthesized.
Psychometric properties assessed
The psychometric properties of outcome measures should
be assessed by their face and content validity, construct
validity, inter-tester and intra-tester reliability, responsive-
ness, interpretability, and acceptability and responder
burden[13]. A full explanation of these concepts is
beyond the scope of this paper and the reader is referred
to Fitzpatrick et al [13]or Norman and Streiner [14], how-
ever a brief definition of these psychometric criteria in the
context of patient-based questionnaires is given in Addi-
tional file 2.
Results
The search yielded 21 hits. After reading the titles and
abstracts, eleven studies were excluded because they did
not include the BCTQ (n = 7); the BCTQ was used as a cri-
terion measure for other instruments (n = 1); the BCTQ
was applied as a measure to ascertain the incidence or
severity of CTS (n = 2) or the BCTQ was compared against
other diagnostic tests designed to detect CTS (n = 1).
A total of ten studies which were primarily designed to
evaluate one or several psychometric properties of the
BCTQ were included [10-12,15-21]. All these studies
applied the questionnaire in adults (aged 18 to 90 years
old) with a diagnosis of carpal tunnel syndrome (Table 1).
Face and content validity were examined in a study which
led to the original development of the BCTQ [10] con-
struct validity was assessed in eight studies, totalling 932
patients; responsiveness in nine studies (986 patients);
test-retest reliability in four studies (126 patients); accept-
ability in eight studies (978 patients); and interpretability
in one study (196 patients) (Table 1). A cross-sectional
design was used in studies assessing face and content
validity [10] and interpretability of the BCTQ [16]. The
four studies which investigated reliability and the nine
studies assessing responsiveness used prospective cohort
data. One study [10] also used retrospective cohort data to
assess responsiveness which has not been reported here
due to its limited value. The study design was observa-
tional for almost all studies, except one [19] which used
data from a randomized controlled trial. Study power was
considered in three out of nine studies. In both the studies
by Bessette et al [16] and Katz et al [18] patients were
recruited through a community-based observational
study in Maine between 1992–93 and therefore it is pos-






































































































































Table 1: Summary of studies assessing the psychometric properties of the Boston Carpal Tunnel Questionnaire (BCTQ)









No. of Patients included in the 
analyses
Amadio et al, 1996 . √√ . √ 33–80 years, 72% 
women
PO Y e s n  =  2 2
Atroshi et al, 1998 . √√ √ √ 21–88 years 66% 
women
P O No Responsiveness/Construct 
validity n = 102
Test-retest n = 22
Bessette et al, 1998 . √√ . √√ > 18 years, 84% 
women
P/C O No n = 196
Gay et al, 2003 . √√ . √ 31–81 years, 55% 
women
PO Y e s n  =  4 0
Greenslade et al, 2004 . . √√ √ > 49 years, 72% 
women
P/C O No Acceptability = 88
Responsiveness n = 57
Test-retest n = 31
Katz et al, 1994 . . √ .
.
. > 18 years, 70% 
women
PR C TY e s n  =  4 3
Katz et al, 1996 . √√ . √ 18–55 years, 70% 
women
P O No n = 268§
Levine et al, 1993 √√ √ √ √ 19–88 years, 75% 
women
P/R/C O No Construct validity n = 43
Responsiveness n = 39
Test-retest n = 31
Mondelli et al, 2002 . √√ . √ 20–90 years, 81% 
women
P O No n = 219
Rosales et al, 2002 √√ 34–63 years 86% 
women
P O No N = 42
Legend:
* P = Prospective, R=Retrospective (R), C = Cross-sectional
§ Workers compensation recipients n = 113, non-recipients n = 155BMC Musculoskeletal Disorders 2006, 7:78 http://www.biomedcentral.com/1471-2474/7/78
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Face and content validity
Only one study evaluated face and content validity of the
BCTQ [10]. The results suggest that the two sub-scales of
the questionnaire measure severity of symptoms and
functional status, which are considered the most impor-
tant reasons for seeking treatment. The Functional Status
Scale covers activities usually performed by a broad range
of patients, but does not include items relevant to specific
groups such as workers.
Construct validity
The BCTQ was compared with 12 other outcome meas-
ures for carpal tunnel syndrome to assess construct valid-
ity (see Table 2). The hypothesized relationships between
the BCTQ and the other outcome measures were assessed
by Spearman rank correlation coefficients [10-12], [15-
18] and by one-way analysis of variance to assess the
extent to which postoperative symptom severity and func-
tional status were related to patient satisfaction[12]. All
observed correlations were in the expected direction.
There were high correlations between the BCTQ and the
Disabilities of the Arm, Shoulder and Hand Question-
naire (DASH)[11] (r = 0.90 and r = 0.87, p < 0.001), and
between the BCTQ and the Arthritis Impact Measurement
Scale-2 (AIMS-2) (r = 0.71 p < 0.01)[15]. Moderate corre-
lations were found between the BCTQ and measures of
symptom relief, generic measures of health status, quality
of life and satisfaction (r-values ranged from 0.50 to
0.56). The analysis of the relationship between patient
satisfaction with the overall results of surgery and the
BCTQ symptom severity and Functional Status Scales
showed worse scores for both scales (p < 0.001) in
patients with lower degree of satisfaction.
The association between the BCTQ and score from clinical
sensory tests was weak (r = 0.15 to 0.17 for Symptom
Severity Scale, and r = 0.24 to 0.42 for functional status
score). The correlations between pinch and grip strength
and the two subscales of the BCTQ were moderate with
higher values for the Functional Status Scale than the
Symptom Severity Scale, whereas sensibility measures
showed a stronger association with the Symptom Severity
Scale (Table 2).
Internal consistency was assessed by correlating all the
scores from the individual items on the BCTQ with the
overall score on the BCTQ. The Cronbach alpha values
ranged from α = 0.80 to 0.90 for the symptom severity
scale and from α = 0.88 to 0.93 for the Functional Status
Scale. A known-groups validation method was applied in
one study. Katz et al [18]compared satisfaction with
change in functional status and in symptom severity
(BCTQ), perceived improvement in quality of life and
perceived improvement in symptoms severity between
recipients and non-recipients of workers' compensation.
As hypothesized, there was evidence of a difference
between the two groups of patients for the BCTQ Func-
tional Status Scale and the Symptom Severity Scale
(Fisher's Z transformation applied to Spearman coeffi-
cient, p < 0.05).
Reliability of the BCTQ
Test-retest reliability was reported in four studies. Levine
et al [10] assessed reliability by administering the ques-
tionnaire on two successive days. Pearson's correlation
coefficients showed high correlation between the scores (r
= 0.91 and 0.93 for symptom severity and Functional Sta-
tus Scales, respectively). Greenslade et al[21] assessed reli-
ability by applying the BCTQ in a two-weekly interval in
patients awaiting surgery. Test-retest plots, difference
between means and Pearson's correlation coefficients
were the measures reported. The mean differences
between test and retest scores (Δ) were not significantly
different from zero, and correlations were high (for the
Symptom Severity Scale Δ = 0.1, 95% CI = -0.1 to 0.3, r =
0.82; for the Functional Status Scale Δ = 0, 95% CI = -0.2
to 0.2, r = 0.79). In a third study [12], the BCTQ was
applied two times before surgery with a mean interval of
14 days. Reliability was measured by difference between
means and Spearman correlation coefficients. The mean
differences between test and retest scores (Δ) were not sig-
nificantly different from zero, and correlations were mod-
erate (for the Symptom Severity Scale Δ = -0.1, p < 0.05, r
= 0.64; for the Functional Status Scale Δ = 0.08, p < 0.05,
r = 0.71). Test-retest reliability was assessed of the Spanish
version of the BCTQ in a prospective study of 42 patients
with confirmed CTS. Pearson correlation coefficients were
reported as r = 0.87 for the Symptom Severity Scale and r
= 0.85 for the Functional Status Scale [20].
Responsiveness of the BCTQ
Responsiveness was assessed in prospective follow-up
studies of surgical interventions only and reported as
effect size (ES) or standard response mean (SRM) (Table
3). The time interval used to calculate change ranged from
1 1/2 to 6 months post-operatively with responsiveness
indices increasing in magnitude through larger time inter-
vals. Two studies assessed responsiveness of the BCTQ
based only on patients reporting greater satisfaction with
the results of surgery [16,19]. Eight studies reported
responsiveness indices separately for each BCTQ subscale.
The effect sizes for the Functional Status Scale ranged from
0.48 at 6 weeks to 1.44 at 27 weeks post-surgery, and for
the Symptom Severity Scale it ranged from 1.13 at 13.5
weeks to 2.33 at 27 weeks post-surgery. Effect sizes and
SRMs for the Symptom Severity Scale tended to be higher
than for the Functional Status Scale, however both scales
yielded moderate (>0.5) to large (>0.8) responsiveness
indices supporting the notion that both scales are sensi-





































































































































Table 2: Comparative measures used in studies assessing the construct validity of the BCTQ
Comparative Measures BCTQ construct validity (Spearman rank correlations)
BCTQ – total score Symptom Severity Score Functional Status Score
Symptoms
Historical-objective severity scale Significant correlation (p < 0.001) (Mondelli et al, 
2002)
Duration of symptoms Significant correlation (p < 0.001) (Mondelli et al, 
2002)
Expectation of symptom relief 0.51 (.56§) (Bessette et al, 1998)
Symptom relief 0.51 (0.56§) (Bessette et al, 1998) 0.59 (Katz et al, 1996)*
0.31 (Katz et al, 1996)**
0.48 (Katz et al, 1996)*
0.19 BCTQ (Katz et al, 1996)**
Nerve conduction studies
Median-nerve sensory conduction velocity 0.11 (Levine et al, 1993) 0.12 (Levine et al, 1993)
Electrophysiological study Significant correlation (p < 0.001) (Mondelli et al, 
2002)
Clinical sensory tests
Semmes-Weinstein monofilaments 0.17 (Levine et al, 1993) 0.24 (Levine et al, 1993)
2-point discrimination 0.15 (Levine et al, 1993) 0.42 (Levine et al, 1993)
Clinical motor tests
Pinch strength 0.73 (Amadio et al, 1996) 0.47 (Levine et al, 1993) 0.60 (Levine et al, 1993)
Grip strength 0.87 (Amadio et al, 1996) 0.38 (Levine et al, 1993) 0.50 (Levine et al, 1993)
Patient-based measures of function
DASH (6 wk post-operative) 0.90 (Gay et al, 2003)
DASH (12 wk pos-toperative) 0.87 (Gay et al, 2003)
Arthritis Impact Measurement Scale 0.71 (Amadio et al, 1996)
General Health Status, Quality of life and satisfaction
36-item Short-form Health Survey 0.70 (Physical role scale) (Amadio et al, 1996) 0.20 – 0.64 ‡ (Preoperative) (Atroshi et al, 1998)
0.33 – 0.64 ‡ (Postoperative) (Atroshi et al, 1998)
0.29 – 0.70 ‡ (Preoperative) (Atroshi et al, 1998)
0.34 – 0.67 ‡ (Postoperative) (Atroshi et al, 1998)
Quality of life 0.50 (0.57§) (Bessette et al, 1998) 0.68 * (Katz et al, 1996)
0.37 ** (Katz et al, 1996)
0.54 * (Katz et al, 1996)
0.41 ** (Katz et al, 1996)
Satisfaction with the outcomes of surgery 0.56 (0.62§) (Bessette et al, 1998) 0.69 * (Katz et al, 1996)
0.37 ** (Katz et al, 1996)
0.55 * (Katz et al, 1996)
0.21 ** (Katz et al, 1996)
Legend:
† – Spearman's rank correlation coefficient and nonparametric test used due to non-normal distribution of the outcome scales.
§-Weighted disease-specific health status measure in BCTQ (For each item subjects were asked how important relief of the specific "symptom" or improvement of the specific "function" was to the decision to have 
surgery.)
‡ – Spearman correlation coefficient (minimum and maximum) between the BCTQ overall score and the 8 scales of the 36-item Short-form Health Survey.
* – Workers' compensation recipients
** – Workers' compensation non-recipientsBMC Musculoskeletal Disorders 2006, 7:78 http://www.biomedcentral.com/1471-2474/7/78
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interventions. The use of Effect sizes as responsiveness
indices tended to generate slightly larger values than when
the SRM was used, hence they should not be compared
directly. The responsiveness of the BCTQ total score was
reported in one prospective cohort study [16] (not in
Table 3). This study assessed the relative responsiveness to
change of generic versus disease-specific as well as
unweighted versus weighted health status measures in car-
pal tunnel syndrome. The weighted disease-specific health
status measure was obtained by asking the subjects how
important relief of the specific symptom or improvement
of the specific function measured by the BCTQ was to the
decision to have surgery. The weighted-BCTQ score (SRM
= 1.56, ES = 1.99) was more responsive than the
unweighted score (SRM = 1.36, ES = 1.57). The generic
health status measures were less sensitive to change than
the BCTQ.
Acceptability of the BCTQ
Acceptability was examined in eight studies (Table 1). The
burden of completing the BCTQ was reported as minimal
in two studies [10,15] based on no loss to follow-up.
Greenslade et al[21] reported the mean time taken to
complete the BCTQ as 5.6 minutes (± 3.5 min). Loss to
follow-up or incomplete responses ranging from 1% to
10% were observed in four of the eight studies
[12,16,17,21] and reached 19% in two studies[11,18].
Bessette et al [16] reported that only nine out of 231 sub-
jects who completed the 6 month follow-up evaluation
did not complete the BCTQ, giving a response rate of
96%. Greenslade et al [21]showed that two out of 312
pre- and post-operative questionnaires returned had miss-
ing information in the Symptom Severity Scale and 17 out
of 312 in the functional status scale, which corresponds to
a response rate of 99% and 95% respectively. There are no
recommendations in the literature to date with regards to
how missing responses should be managed and what the
threshold for number of incomplete items is which would
render the subscale data invalid.
Interpretability of the BCTQ
Interpretability was assessed in a study including 196 sub-
jects[16]. Using the satisfaction with the outcomes of sur-
gery as a discrete variable (unsatisfied, somewhat
satisfied, and very or completely satisfied), the minimal
clinically important difference (MCID) was estimated as
the mean difference between the BCTQ scores before sur-
gery and at 6 months after surgery for the unsatisfied and
somewhat satisfied patients. The MCID is 0.74 for the
BCTQ (total score based on the average of both subscales
with scale ranges from 1 to 5), a value considered superior
to generic measures, e.g. SF-36, in distinguishing clinically
important differences after carpal tunnel release. The
MCID for individual scales has not been reported, how-
ever Atroshi et al [12] also presented summary statistics
for each subscale according to those patients who were
satisfied, somewhat satisfied and dissatisfied. The mean
change between pre- and postoperative scores for the
Symptom Severity Scale for the satisfied, somewhat satis-
fied and dissatisfied patients were 1.6, 1.0 and 0.2 respec-
tively, indicating that a minimum difference of 0.8 can be
deemed as clinically important using patients satisfaction
as a criterion. For the Functional Status Scale the mean
change pre- and post-operatively were 1.0, 0.6 and 0.1 for
the satisfied, somewhat satisfied and dissatisfied patients
respectively, suggesting that a value of 0.5 is clinically
important.
Discussion
The ten selected studies presented some strength. The
studies sampled a wide age range of participants, which is
desirable considering that items of relevance for the
young and the elderly are incorporated [13,22]. Sample
sizes appeared to be adequate to yield stable correlations,
although power calculations were reported in three stud-
ies only. The studies used prospective cohort data to assess
the majority of the BCTQ psychometric properties. Pro-
spective cohort studies are at greater risk of missing data
during the follow-up phase which in turn can lead to sys-
tematic measurement error. However this does not appear
to be a major problem in these studies, since participation
rates were relatively high with losses of follow-up varying
from none to 19%.
Limitations must also be acknowledged. Firstly, none of
the ten studies assessed all the psychometric properties,
making comparisons difficult specially regarding face and
content validity, acceptability, interpretability and relia-
bility. Secondly, the factor structure of the BCTQ, an
aspect of construct validity, has not been examined in the
selected studies. Factor analysis is a method of assessing
the construct validity of a questionnaire. In confirmatory
factor analysis, the scores from each item in the scale
would show high loadings, expressed as high Eigenvalues,
on one of the predicted factors (e.g., symptom severity
and functional status of the BCTQ). It has been hypothe-
sized that the BCTQ comprises a two-factor structure con-
sistent with symptom severity and functional status [10].
Because the constructs assessed are so distinct (symptom
severity and functional status), it is likely that the BCTQ
total score is less informative and helpful for clinical pur-
poses even though four studies reported the total score.
Also, Katz et al[18] found the two-factor structure consist-
ent with the symptom severity and factor structure scales
in workers' compensation recipients, however this large
study did not investigate the BCTQ factor structure; either
confirming the original structure or suggesting an alterna-
tive factor models may provide a better explanation of
that data. Thirdly, test-retest reliability was reported in





































































































































Table 3: Responsiveness Indices for the BCTQ Symptom Severity and Functional Status Scales
Study Responsiveness Indices (Measure of Clinical Change)
BCTQ Functional Status Score (FS) BCTQ Severity of Symptoms Score (SS) Assessment interval
Amadio et al, 1996 SRM = 1.26 SRM = 1.75 Before and 13.5 weeks post surgery (n = 22)
Atroshi et al, 1998 SRM = 0.94 (0.72–1.16)
ES = 0.94
SRM = 1.7 (1.4–2.0)
ES = 2.1
Before and 13.5 weeks post surgery (n = 102)
Gay et al, 2003 At 6 weeks after surgery SRM = 0.46; ES = 0.48
At 12 weeks after surgery SRM = 1.05; ES = 1.05
At 6 weeks after surgery SRM = 1.67; ES = 1.74
At 12 weeks after surgery SRM = 2.01; ES = 1.96
before, 6 and 12 weeks post surgery (n = 34)
Greenslade et al, 2004 SRM = 0.62 SRM = 1.07 before and 13.5 weeks post surgery (n = 57)




before and 13.5 weeks post surgery (n = 43)
Katz et al, 1996* Male WC/WCNon ES = 0.65/ES = 0.76
Female WC/WCNon ES = 1.25/ES = 1.44
Male WC/WCNon ES = 1.43/ES = 1.33
Female WC/WCNon ES = 1.63/ES = 2.13
before and 27 weeks post surgery (n = 268)
Levine et al, 1993 SRM = 0.71†
greater satisfaction with the outcomes of surgery versus 
improvement of FS = 0.50 (p < 0.01)
SRM = 1.13†
greater satisfaction with the outcomes of surgery versus 
improvement of SS = 0.54 (p < 0.01)
before and 13.5 weeks after surgery (n = 26)
Mondelli et al, 2002 ES = 1.23§ ES = 2.33§ before and 27 weeks post surgery (n = 219)
Legend:
WC – Workers' compensation recipients
WCNon – Workers' compensation Nonrecipients
* ES were not reported in paper but have been calculated based on values given in tables
† responsiveness reported as ES, however calculation given is SRM (mean change/S.D change)
§responsiveness assessed as differences but ES calculated from values given in paperBMC Musculoskeletal Disorders 2006, 7:78 http://www.biomedcentral.com/1471-2474/7/78
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in two of them[10,20], a statistical approach recognized
as inappropriate as it only measures the strength of asso-
ciation between scores and not agreement[23]. Forthly, in
one study [10] the analyses of responsiveness of the BCTQ
compared data from two independent cohorts (one pro-
spective and another retrospective). It is likely that the
information obtained retrospectively is less accurate than
the prospective one.
Validity of the BCTQ was assessed in terms of face, content
and construct validity. Face and content validity were
assessed through consultation with individuals with rele-
vant expertise in order to generate the content of the ques-
tionnaire. The content of the BCTQ had been examined in
one study[10], suggesting that the questionnaire items
match the test objectives and the impact of carpal tunnel
syndrome on patients' daily life. The construct validity of
the BCTQ had been assessed in the majority of the ten
studies. In the selected studies construct validity it was
assessed as the extent to which the items of the BCTQ
'behaved' the way that the construct it purports to measure
(that is symptom severity and functional status) should
'behave' with regard to other established measures (e.g.,
the Disabilities of the Arm, Shoulder, and Hand Ques-
tionnaire, pinch and grip strength, satisfaction with the
outcomes of surgery). Stronger correlations were observed
between the BCTQ and the other disease- and region-spe-
cific measures such as the DASH and Arthritis Impact
Measurement Scale, than between the BCTQ and generic
objective measures such as SF-36 and Quality of Life
Questionnaire indicating greater overlap between the
former measures. The BCTQ also demonstrates construct
validity when its internal consistency was examined. A
high Cronbach alpha indicates homogeneity of items and
supports the validity of the construct being tested [14].
Responsiveness to clinical change is another important
feature of an outcome measure. The data on effect sizes
and standard response means demonstrated that the
Symptom Severity Scale and Functional Status Scales are
able to detect clinically meaningful change resulting from
the treatment for carpal tunnel syndrome and yielded
large effect sizes over a 6 month interval. However in two
of the studies the data on responsiveness were based on a
subgroup of patients reporting greater satisfaction with
surgery. Responsiveness indices in these are therefore
likely to be larger than in the other studies. Using a
responsive outcome measure will facilitate the detection
of moderate treatment effects in clinical research.
The BCTQ has shown good levels of acceptability with
response rates of 90% and above and takes less than 10
minutes to complete. The interpretability has been
assessed in relation to patient satisfaction with the out-
comes of surgery and an overall difference of 0.74 has
been designated as the minimally clinical important dif-
ference.
This review considered English language publications
only, however there are a number of published studies
which have used translations of the BCTQ into other lan-
guages including Italian [24] Swedish [12] Portuguese
[25] and Spanish [20] widening the applicability of the
BCTQ to non-English speaking settings.
Scale development is an ongoing process which may
never be complete. The properties such as the validity,
reliability and responsiveness investigated to date are not
fixed properties but specific to the instrument used in a
given situation and with a given population. The BCTQ
was developed for use in heterogeneous samples of
patients of a wide age range with CTS. Further research is
needed to examine the consistency of its psychometric
properties, with special attention to the factor structure,
among specific populations, test-retest reliability using
appropriate statistical measures and defining the MCID
for each subscale against appropriate external criteria.
Clinicians looking for a disease-specific measure for
assessing pre- and post-operative symptom severity and
functional status can be confident that the BCTQ is
responsive to change, repeatable over time and that the
scales measure what they purport to measure. The BCTQ
is also acceptable and quick to administer and as it relies
on self-report can be applied via postal methods.
Conclusion
In summary, the BCTQ offers a standardised patient-
based outcome measure of symptom severity and func-
tional status for which there is good evidence on validity,
reliability and responsiveness and it should be recom-
mended for inclusion in future trials on carpal tunnel
interventions.
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